VivoSeq
Explore
Companies
Drugs
Sign In
Report Error
Licenced Measles-Rubella vaccine
Phase 2
Vaccine
U
University of Oxford
1
Indications
1
Total Trials
1
Active Trials
0
Competitors
Pipeline
Status by Indication
[3]
[1]
Indication
Preclinical
Phase 1
Phase 2
Phase 3
Approved
Measles
Recruiting
Preclinical
Phase 1
Phase 2
Phase 3
Approved
Measles
Phase 2
Recruiting
Clinical
Trials by Indication
[1]
Measles
1 trial
Earlier Prime-BOOST Schedule to Improve MEasles Protection in High Burden Settings
Recruiting
·
U
University of Oxford
·
Phase 2
·
NCT06667206
·
450 enrolled
Sources
References
[1]
ClinicalTrials.gov
—
1 trial record for Licenced Measles-Rubella vaccine. U.S. National Library of Medicine, National Institutes of Health.
[2]
ChEMBL
—
Licenced Measles-Rubella vaccine compound record. European Bioinformatics Institute (EMBL-EBI).
[3]
Open Targets Platform
—
Drug–disease associations for Licenced Measles-Rubella vaccine. EMBL-EBI & Wellcome Sanger Institute.
[4]
SEC EDGAR
—
University of Oxford company filings. U.S. Securities and Exchange Commission.
Details
Drug Info
Quick Facts
Modality
Vaccine
[2]
Highest Phase
Phase 2
[1]
Company
U
University of Oxford
Related News